Anti-Interleukin-17 Therapy of Severe Psoriatic Patients Results in an Improvement of Serum Lipid and Inflammatory Parameters’ Levels, but Has No Effect on Body Composition Parameters

Anti-Interleukin-17 Therapy of Severe Psoriatic Patients Results in an Improvement of Serum Lipid and Inflammatory Parameters’ Levels, but Has No Effect on Body Composition Parameters

BACKGROUND: Psoriasis is frequently accompanied by metabolic syndrome. Effect of anti-tumor necrosis factor therapies on increases in body weight is well-known. Data on the effects of interleukin-17 inhibitors are limited. Authors determined the effect of anti-interleukin-17 therapies on the body co...

Full description

Bibliographic Details
Main Authors: Éva Anna Piros, Ákos Szabó, Fanni Rencz, Valentin Brodszky, Norbert Wikonkál, Pál Miheller, Miklós Horváth, Péter Holló
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Life
Subjects:
psoriasis
body composition
interleukin-17 inhibitor
metabolic syndrome
obesity
Online Access:https://www.mdpi.com/2075-1729/11/6/535

Internet

https://www.mdpi.com/2075-1729/11/6/535

Similar Items